Form D · Biotechnology
Viela Bio, Inc.
Gaithersburg, MD · CIK 0001734517
Offering snapshot reported Jun 26, 2019 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 12, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 26, 2019 | Initial | $75,000,000 | No comparison | 9 | SEC filing |
| Mar 15, 2018 | Initial | $282,253,240 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $250K
- Finders' fees
- $0
- Form D file number
- 021-342862
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Solebury Capital LLC | 14399 |
Source: Form D, filed Jun 26, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Yanling Cao | Director |
| Edward Hu | Director |
| Bahija (Bing) Jallal | Director |
| Ting (Bing) Jia | Director |
| Matthew (Bing) Pietras | Executive |
| Tyrell Rivers | Director |
| Pascal Soriot | Director |
| Xiaomeng Tong | Director |
| Andreas Wicki | Director |
| Wenkai Xiang | Director |
| Zhengbin (Bing) Yao | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1 Medimmune Way
Gaithersburg, MD, 20878
Gaithersburg, MD, 20878